Studies on anticancer activities of lactoferrin and lactoferricin

Curr Protein Pept Sci. 2013 Sep;14(6):492-503. doi: 10.2174/13892037113149990066.

Abstract

This review mainly summarizes results of recent studies on the anticancer activity of the multifunctional protein lactoferrin (Lf) and its derived peptide lactoferricin (Lfcin). The basic information on Lf and Lfcin, such as their sources, structures, and biological properties which favor their antitumor activity is introduced. The major anticancer mechanisms of Lf and Lfcin including cell cycle arrest, apoptosis, anti-angiogenesis, antimetastasis, immune modulation and necrosis are discussed. Other information from in vivo studies employing a mouse model is also provided. In addition, the roles of talatoferrin and delta lactoferrin, as well as improvement in drug delivery will be covered.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Angiogenesis Inhibitors / chemistry
  • Angiogenesis Inhibitors / immunology
  • Angiogenesis Inhibitors / pharmacology*
  • Animals
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / immunology
  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects
  • Cell Cycle / drug effects
  • Humans
  • Lactoferrin / chemistry
  • Lactoferrin / immunology
  • Lactoferrin / pharmacology*
  • Necrosis / drug therapy
  • Necrosis / immunology
  • Necrosis / pathology
  • Neoplasms / drug therapy*
  • Neoplasms / immunology
  • Neoplasms / pathology
  • Neovascularization, Pathologic / drug therapy
  • Neovascularization, Pathologic / immunology
  • Neovascularization, Pathologic / pathology

Substances

  • Angiogenesis Inhibitors
  • Antineoplastic Agents
  • lactoferricin B
  • Lactoferrin